Bayside, NY, United States of America

Mario DiPaola

This inventor holds 2 USPTO granted patents. Top assignee: Interferon Sciences, Inc.. Active years: 1996-1997.


% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 135(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Mario DiPaola

Introduction

Mario DiPaola is a notable inventor based in Bayside, NY (US). He has made significant contributions to the field of antiviral therapies, particularly through his work with alpha interferon compositions. With a total of 2 patents to his name, DiPaola's innovations are aimed at enhancing the treatment of viral infections.

Latest Patents

DiPaola's latest patents include a composition containing human alpha interferon species proteins. This invention provides alpha interferon compositions comprising one or a mixture of selected highly antiviral interferon proteins, which compositions are characterized by increased anti-viral activity. These compositions may be used therapeutically in the treatment of viral infections, particularly retroviral or hepatitis infections, or as additives to conventional antiviral agents to increase their antiviral potency.

Career Highlights

Mario DiPaola is associated with Interferon Sciences, Inc., where he has been instrumental in developing innovative antiviral therapies. His work has contributed to advancements in the treatment of various viral infections, showcasing his commitment to improving public health through scientific research.

Collaborations

Some of his notable coworkers include Douglas Testa and Mei-June Liao, who have collaborated with DiPaola on various projects related to antiviral research.

Conclusion

Mario DiPaola's contributions to the field of antiviral therapies through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…